Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9de32f6289dcf304fcf935f042feceae |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 |
filingDate |
2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a047bd1ba1b682ca7f7c0e237a375a90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8260c043ae20dc3cb3d69c7abfba2eb1 |
publicationDate |
2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019153080-A1 |
titleOfInvention |
Humanized Antibodies That Recognize Alpha-Synuclein |
abstract |
The present application discloses humanized 1H7 antibodies. The antibodies bind to human alpha synuclein and can be used for treatment and diagnosis of Lewy body disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11345749-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10723792-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669331-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513555-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10875909-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10875910-B2 |
priorityDate |
2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |